AAV-dependent targeting of myostatin function: Follistatin strikes back at muscular dystrophy

Gene Therapy

Volumn 15, Issue 15, 2008, Pages 1075-1076

  Colussi, C ^a   Gaetano, C ^a   Capogrossi, M C ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; COMPLEMENTARY DNA; DYSTROPHIN; FOLLISTATIN; HISTONE DEACETYLASE INHIBITOR; MYOSTATIN BINDING PROTEIN; NITRIC OXIDE DONOR;

ALTERNATIVE RNA SPLICING; CELL THERAPY; DUCHENNE MUSCULAR DYSTROPHY; GENE MUTATION; GENE THERAPY; GENE TRANSFER; MUSCLE REGENERATION; MUSCULAR DYSTROPHY; NONHUMAN; NOTE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION; VIRAL GENE DELIVERY SYSTEM; VIRUS IMMUNITY;

ANIMALS; DEPENDOVIRUS; FOLLISTATIN; GENE THERAPY; GENETIC VECTORS; HUMANS; MICE; MICE, INBRED MDX; MUSCULAR DYSTROPHY, DUCHENNE; PROTEIN ISOFORMS; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 47549114628     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.95     Document Type: Note

References (10)

1. Alter J, Lou F, Rabinowitz A, Yin H, Rosenfeld J, Wilton SD et al. Systemic delivery of morpholino oligonucleotide restores dystrophin expression body-wide and improves dystrophic pathology. Nat med 2006; 12: 175-177.
2. Denti MA, Rosa A, D'Antona G, Sthandier O, De Angelis FG, Nicoletti C et al. Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model. Proc Natl Acad Sci USA 2006; 103: 3758-3763.
3. Minetti GC, Colussi C, Adami R, Serra C, Mozzetta C, Parente V et al Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors. Nat med 2006; 12: 1147-1150.
4. Pisconti A, Brunelli S, Di Padova M, De Palma C, Deponti D, Baesso S et al. Follistatin induction by nitric oxide through cyclic GMP: A tightly regulated signaling pathway that controls myoblast fusion. J cell biol 2006; 172: 233-244.
5. Sciorati C, Galvez BG, Brunelli S, Tagliafico E, Ferrari S, Cossu G et al. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J cell sci 2006; 119: 5114-5123.
6. Wagner KR, McPherron AC, Winik N, Lee SJ. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann neurol 2002; 52 832-836.
7. Bogdanovich S, Krag TO, Barton ER, Morris LD, Whittemore LA, Ahima RS et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002; 420: 418-421.
8. Haidet AM, Rizo L, Handy C, Umapathi P, Eagle A, Shilling C et al. Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA 2008; 105: 4318-4322.
9. Wang Z, Zhu T, Qiao C, Zhou L, Wang B, Zhang J et al. Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart. Nat biotechnol 2005; 23: 321-328.
10. Zaiss AK, Muruve DA. Immunity to adeno-associated virus vectors in animals and humans: A continued challenge. Gene Therapy 2008; 15: 808-816.